Panamerican Journal of Trauma, Critical Care & Emergency Surgery

Register      Login

VOLUME 10 , ISSUE 2 ( May-August, 2021 ) > List of Articles


Coronavirus Disease (SARS-CoV-2) and Neurocritical Care: Challenges for Neurosurgeons

Moshiur Rahman

Keywords : Neurocritical care, Trauma, Trauma surgery

Citation Information : Rahman M. Coronavirus Disease (SARS-CoV-2) and Neurocritical Care: Challenges for Neurosurgeons. Panam J Trauma Crit Care Emerg Surg 2021; 10 (2):89-90.

DOI: 10.5005/jp-journals-10030-1317

License: CC BY-NC 4.0

Published Online: 27-08-2021

Copyright Statement:  Copyright © 2021; The Author(s)


Neurocritical care is an important and integral part of neurosurgical management. In this global war without any smoke, it is a pivotal need for a holistic effort, as a health unit, in combating the virus. In this new era of SARS-CoV-2, neurosurgeons must acknowledge the insights regarding neurocritical care to safeguard our patients and quest for their best possible clinical outcome, working in harmony and sync with other clinical specialties. SARS-CoV-2 has very similar properties to the already known SARS-CoV, demonstrating in animal models its ability to invade neural tissues, with a high preponderance to neurons in the respiratory centers. The exact cause must be differentiated from nonspecific causes from those caused valid or indirect way by the infection, including infectious, para-infectious, and post-infectious encephalitis, hyper-coagulable states prompting stroke. To improve the quality of life of patients, roping in of the neurological manpower is mandatory in ICU, ward, research as well as neurological, neuropsychological, and neurocognitive rehabilitation including domiciliary care in search of a SARS-CoV-2 free world.

  1. WHO, Report of the WHO-China Joint Mission on Coronavirus Disease 2019 (COVID-19) 2020 [Available from:].
  2. Li YC, Bai WZ, Hashikawa T. The neuroinvasive potential of SARS-CoV2 may play a role in the respiratory failure of COVID-19 patients. J Med Virol 2020;92(6):552–555. DOI: 10.1002/jmv.25728.
  3. Ellul MA, Benjamin L, Singh B, et al. Neurological associations of COVID-19. Lancet Neurol 2020;19(9):767–783. DOI: 10.1016/S1474-4422(20)30221-0.
  4. Richardson PJ, Ottaviani S, Prelle A, et al. CNS penetration of potential anti-COVID-19 drugs. J Neurol. 2020;267(7):1880–1882. DOI: 10.1007/s00415-020-09866-5.
  5. Sasidharan PK. Cerebral vein thrombosis misdiagnosed and mismanaged. 2012;2012:210676. DOI: 10.1155/2012/210676.
  6. Vanamoorthy P, Singh GP, Bidkar PU, et al. The Neurocritical Care Society of India (NCSI) and the Indian Society of Neuroanaesthesiology and Critical Care (ISNACC) joint position statement and advisory on the practice of neurocritical care during the COVID-19 pandemic. J Neuroanaesthesiol Crit Care 2020;7(03). DOI: 10.1055/s-0040-1714648.
  7. Lu X, Jiang L, Chen T, et al. Continuously available ratio of SpO2/FiO2 serves as a noninvasive prognostic marker for intensive care patients with COVID-19. Respir Res 2020;21(1):194. DOI: 10.1186/s12931-020-01455-4.
  8. Gavin W, Campbell E, Zaidi SA, et al. Clinical characteristics, outcomes and prognosticators in adult patients hospitalized with COVID-19. Am J Infect Control 2020;49(2):158–165. DOI: 10.1016/j.ajic.2020.07.005.
  9. Helbok R, Öztürk S, COVID-19 Statement of the EAN Scientific Panel Neurocritical care 2020 [updated 2020/04/16/T13:57:35+00:00. Available from:
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.